Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT04002518

MDR - Biomet Cannulated Screws

The objective of this retrospective enrollment/prospective follow up study is to collect data confirming safety, performance, and clinical benefits of the Biomet Cannulated Bone Screw System (Implants and Instrumentation) when used according to the approved Indications for Use (IFU).

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Zimmer Biomet, Warsaw, Indiana, United States

Loading trial locations.

About this study

The objective of this retrospective enrollment/prospective follow up study is to collect data confirming safety, performance, and clinical benefits of the Biomet Cannulated Bone Screw System (Implants and Instrumentation) when used according to the approved Indications for Use (IFU).

Safety will be established by recording the incidence and frequency of complications and adverse events. Relationship of the events to either implant or instrumentation should be specified.

Performance and clinical benefits will be assessed by analyzing fracture healing/fusion and the overall pain and functional performance of subjects who received the Biomet Cannulated Bone Screws by recording survey questions. Zimmer Biomet defines the expected performance rate for Cannulated Screws for long and small bone fractures to be a union rate of at least 81% at 8-12 months.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient must be 18 years of age or older.

All patients operated on for the following indications:

  • Group 1, Small Cannulated Screws (4.0mm and smaller diameter) are intended for use in:
  • Fixation of small bones, including those in the foot, patella, ankle, wrist and elbow.
  • Arthrodesis of the foot, wrist and elbow.
  • Small and long bone osteotomies.
  • Fracture fixation of small bones, small bone fragments and long bones.
  • Group 2, Large Cannulated Screws (5mm and larger in diameter) are intended for use in:
  • Fixation of fractures in long bones and long bone fragments.
  • Long bone osteotomies (femur, tibia, foot, ankle, olecranon).
  • Arthrodesis and fracture fixation of the foot and ankle, such as Jones fractures of the fifth metatarsal, and Calcaneal fractures.
  • Group 3, Large Cannulated Screws (6.5mm and larger in diameter) are intended for use in:
  • Slipped capital femoral epiphysis
  • Pediatric femoral neck fractures
  • Tibial plateau fractures
  • SI joint disruptions
  • Intercondylar femur fractures
  • Subtalar arthrodesis
  • Fixation of pelvis and iliosacral joint
  • Patients must have the ability and willingness to follow instructions, including control of weight and activity levels.
  • Patient must have a good nutritional state.

Exclusion criteria

  • Infections.
  • Patient conditions including blood supply limitations, insufficient quantity or quality of bone.
  • Patients with mental or neurologic conditions who are unwilling or incapable fo following postoperative care instructions.
  • Foreign body sensitivity where material sensitivity is suspected or unknown, testing is to be completed prior to implantation of the device.
  • Patient is a prisoner.
  • Patient is a current alcohol or drug abuser.
  • Patient is known to be pregnant or breastfeeding.
  • Patient has a psychiatric illness or cognitive deficit that will not allow for proper informed consent.

Treatment and study plan

Biomet Cannulated Screw: 3.0, 4.0, 5.0, 6.5, and 8.0mm screws.

Device

Treatment of identified conditions, i.e. fracture fixation, arthrodesis, osteotomy, with a cannulated screw.

Primary outcomes

  1. Device Safety Assessed Through the Incidence and Frequency of Revisions, Complications, and Adverse Events

    Time frame: Out to12+ months

    Assessment of safety by recording and analyzing the incidence and frequency of revisions, complications, and adverse events.

Secondary outcomes

  1. Device Performance and Clinical Benefits Assessed by a Patient Questionnaire Case Report Form

    Time frame: Out to 12+ months

    Performance and clinical benefits demonstrated by the assessment of survey questions.

  2. Device Performance and Clinical Benefits Assessed by a Follow-Up Analysis Case Report Form

    Time frame: Out to 12+ months

    Performance and clinical benefits demonstrated by the assessment of fracture healing/fusion and survey questions.

Sponsors and collaborators

Lead sponsor

Zimmer Biomet

Industry

Registry information

Official study title

Post-market Clinical Follow-up Study to Provide Safety, Performance and Clinical Benefits Data of the Biomet Cannulated Bone Screw System (Implants and Instrumentation) - A Retrospective/Prospective Study

Important dates

Study start
2019
Primary completion
2026
Study completion
2026
First posted
Jun 28, 2019
Registry last updated
Jul 9, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.